CIK 0000812796
- Non-accelerated filer
- Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411505029
- Phone
- +1 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-18 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +19,868 | 19,868 | ||
| 2015-06-18 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +19,868 | 19,868 | ||
| 2015-04-09 | ZELDIS JEROME B Director | Exercise or conversion | +17,857 | $0.61 | $11K | 66,666 |
| 2015-04-09 | ZELDIS JEROME B Director | Exercise or conversion · Common Stock Warrant | −17,857 | 0 | ||
| 2015-04-09 | Brownlie Keith L Director | Exercise or conversion | +14,286 | $0.61 | $9K | 50,000 |
| 2015-04-09 | Brownlie Keith L Director | Exercise or conversion · Common Stock Warrant | −14,286 | 0 | ||
| 2014-12-24 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase · Common Stock Warrant | +4,959 | 4,959 | ||
| 2014-12-24 | Warusz Joseph Michael VP of Finance/Acting CFO | Purchase · Common Stock Warrant | +4,959 | 4,959 | ||
| 2014-12-22 | SCHABER CHRISTOPHER J Chairman, CEO and President | Purchase | +8,265 | $1.21 | $10K | 75,761 |
| 2014-12-22 | Warusz Joseph Michael VP of Finance/Acting CFO | Purchase | +8,265 | $1.21 | $10K | 12,955 |
| 2014-12-04 | Warusz Joseph Michael VP of Finance/Acting CFO | Grant or award · Option (Right to Buy) | +45,000 | 45,000 | ||
| 2014-12-04 | Straube Richard Sr VP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2014-12-04 | SCHABER CHRISTOPHER J Chairman, CEO and President | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2014-08-05 | Brughera Marco Maria Director | Exercise or conversion | +7,500 | $2.01 | $15K | 7,500 |
| 2014-08-05 | Brughera Marco Maria Director | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 7,500 | ||
| 2014-06-19 | LAPOINTE ANTHONY GREGG Director | Grant or award · Stock Option (Right to Buy) | +13,669 | 13,669 | ||
| 2014-06-19 | Brughera Marco Maria Director | Grant or award · Stock Option (Right to Buy) | +13,669 | 13,669 | ||
| 2014-06-19 | Brownlie Keith L Director | Grant or award · Stock Option (Right to Buy) | +13,669 | 13,669 | ||
| 2014-06-19 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +13,669 | 13,669 | ||
| 2014-06-19 | RUBIN ROBERT J. Director | Grant or award · Stock Option (Right to Buy) | +13,669 | 13,669 |
Page 11 of 14 · 277 trades